Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Research Article
  • Published:

Targeted beta-globin gene conversion in human hematopoietic CD34+ and LinCD38 cells

Abstract

Chimeric oligonucleotides have been used successfully to correct point and frameshift mutations in several cell types, as well as in animal and plant models. However, their application to primitive human blood cells has been limited. In this investigation, chimeric oligonucleotides designed to direct a site-specific nucleotide exchange in the human β-globin gene (an A to T substitution within codon 6) were introduced into normal human CD34+ and LinCD38- cells via microinjection. This A to T nucleotide exchange introduces the single site mutation responsible for sickle cell anemia. In 23% of experimental samples, gene conversion was detected in the progeny of microinjected CD34+ and LinCD38 cells that were cultured for at least 4 weeks. In addition, gene conversion was detected in the erythroid progeny of LinCD38 cells at the mRNA level. Conversion rates as high as 10–15% in 11% (five of 44) of experimental samples were confirmed by allele-specific PCR and sequence analysis of genomic DNA from the progeny of microinjected LinCD38 cells. Given that as few as 10% normal hematopoietic cells are sufficient to keep patients free of sickle cell disease, the level of conversion we have achieved in some samples may well be of therapeutic benefit in patients with sickle cell disease.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2
Figure 3
Figure 4
Figure 5
Figure 6

Similar content being viewed by others

References

  1. Kmiec E.B. . Targeted gene repair (editorial) Gene Therapy 1999 6: 1 1

    Article  CAS  Google Scholar 

  2. Cole-Strauss A. et al. Correction of the mutation responsible for sickle cell anemia by an RNA-DNA oligonucleotide Science 1996 273: 1386 1386

    Article  CAS  Google Scholar 

  3. Kren B.T., Cole-Strauss A., Kmiec E.B., Steer C.J. . Targeted nucleotide exchange in the alkaline phosphatase gene of HuH-7 cells mediated by a chimeric RNA/DNA oligonucleotide Hepatology 1997 25: 1462 1462

    Article  CAS  Google Scholar 

  4. Kren B.T., Bandyopadhyay P., Steer C.J. . In vivo site-directed mutagenesis of the factor IX gene by chimeric RNA/DNA oligonucleotides Nat Med 1998 4: 285 285

    Article  CAS  Google Scholar 

  5. Alexeev V., Yoon K. . Stable and inheritable changes in genotype and phenotype of albino melanocytes induced by an RNA-DNA oligonucleotide Nat Biotechnol 1998 16: 1343 1343

    Article  CAS  Google Scholar 

  6. Lai L.W., Lien Y.H. . Homologous recombination based gene therapy Exp Nephrol 1999 7: 11 11

    Article  CAS  Google Scholar 

  7. Beetham P.R. et al. A tool for functional plant genomics: chimeric RNA/DNA oligonucleotides cause in vivo gene-specific mutations Proc Natl Acad Sci USA 1999 96: 8774 8774

    Article  CAS  Google Scholar 

  8. Zhu T. et al. Targeted manipulation of maize genes in vivo using chimeric RNA/DNA oligonucleotides Proc Natl Acad Sci USA 1999 96: 8768 8768

    Article  CAS  Google Scholar 

  9. Kren B.T. et al. Correction of the UDP-glucuronosyltransferase gene defect in the gunn rat model of Crigler–Najjar syndrome type I with a chimeric oligonucleotide Proc Natl Acad Sci USA 1999 96: 10349 10349

    Article  CAS  Google Scholar 

  10. Rando T.A., Disatnik M.H., Zhou L.Z. . Rescue of dystrophin expression in mdx mouse muscle by RNA/DNA oligonucleotides Proc Natl Acad Sci USA 2000 97: 5363 5363

    Article  CAS  Google Scholar 

  11. Alexeev V. et al. Localized in vivo genotypic and phenotypic correction of the albino mutation in skin by RNA-DNA oligonucleotide Nat Biotechnol 2000 18: 43 43

    Article  CAS  Google Scholar 

  12. Bartlett R.J. et al. In vivo targeted repair of a point mutation in the canine dystrophin gene by a chimeric RNA/DNA oligonucleotide Nat Biotechnol 2000 18: 615 615

    Article  CAS  Google Scholar 

  13. Rice M.C., Bruner M., Czymmek K., Kmiec E.B. . In vitro and in vivo nucleotide exchange directed by chimeric RNA/DNA oligonucleotides in Saccharomyces cerevisae Mol Microbiol 2001 40: 857 857

    Article  CAS  Google Scholar 

  14. Davis B.R. et al. Glass needle-mediated microinjection of macromolecules and transgenes into primary human blood stem/progenitor cells Blood 2000 95: 437 437

    CAS  PubMed  Google Scholar 

  15. Xu R., Reems J.A. . Umbilical cord blood progeny cells that retain a CD34+ phenotype after ex vivo expansion have less engraftment potential than unexpanded CD34+ cells Transfusion 2001 41: 213 213

    Article  CAS  Google Scholar 

  16. Bhatia M. et al. Purification of primitive human hematopoietic cells capable of repopulating immune-deficient mice Proc Natl Acad Sci USA 1997 94: 5320 5320

    Article  CAS  Google Scholar 

  17. Bandyopadhyay P. et al. Nucleotide exchange in genomic DNA of rat hepatocytes using RNA/DNA oligonucleotides. Targeted delivery of liposomes and polyethyleneimine to the asialoglycoprotein receptor J Biol Chem 1999 274: 10163 10163

    Article  CAS  Google Scholar 

  18. Cole-Strauss A. et al. Targeted gene repair directed by the chimeric RNA/DNA oligonucleotide in a mammalian cell-free extract Nucleic Acids Res. 1999 27: 1323 1323

    Article  CAS  Google Scholar 

  19. Harrison G.S. et al. Optimization of gene transfer using cationic lipids in cell lines and primary human CD4+ and CD34+ hematopoietic cells Biotechniques 1995 19: 816 816

    CAS  Google Scholar 

  20. Van Tendeloo V.F. et al. High-level transgene expression in primary human T lymphocytes and adult bone marrow CD34+ cells via electroporation-mediated gene delivery Gene Therapy 2000 7: 1431 1431

    Article  CAS  Google Scholar 

  21. Xiang Y. et al. Targeted gene conversion in a mammalian CD34+-enriched cell population using a chimeric RNA/DNA oligonucleotide J Mol Med 1997 75: 829 829

    Article  CAS  Google Scholar 

  22. Walters M.C. et al. Bone marrow transplantation for sickle cell disease N Engl J Med 1996 335: 369 369

    Article  CAS  Google Scholar 

  23. Gamper H.B. et al. A plausible mechanism for gene correction by chimeric oligonucleotides Biochemistry 2000 39: 5808 5808

    Article  CAS  Google Scholar 

  24. Saiki R.K. et al. Enzymatic amplification of beta-globin genomic sequences and restriction site analysis for diagnosis of sickle cell anemia Science 1985 230: 1350 1350

    Article  CAS  Google Scholar 

  25. Malik P. et al. An in vitro model of human red blood cell production from hematopoietic progenitor cells Blood 1998 91: 2664 2664

    CAS  Google Scholar 

Download references

Acknowledgements

The work was funded in part by NIH grant R01HL58583 (to EBK). We thank David B Brown, ND Victor Carsrud, Judith Yannariello-Brown, Aqing Yao and Tamara V Tsulaia for their excellent scientific and technical guidance, Dr Nicole L Prokopishyn and Barbara L Chow for their critical review of this manuscript. We also thank Hetal Parekh-Olmedo and Alyson Cole-Strauss for their technical assistance during the early stages of the work.

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Liu, H., Agarwal, S., Kmiec, E. et al. Targeted beta-globin gene conversion in human hematopoietic CD34+ and LinCD38 cells. Gene Ther 9, 118–126 (2002). https://doi.org/10.1038/sj.gt.3301610

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.gt.3301610

Keywords

This article is cited by

Search

Quick links